February 27, 2017
Martin Åmark, CEO Xbrane Biopharma
Click here to watch/listen to the conference >>
Banvaktsvägen 22 17148 Solna
Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. The segment have a high entry barrier, driven by high production complexity and the need of specific Know- How.